Group One Trading, L.P. Biocept Inc Transaction History

Group One Trading, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.24 - $0.62 $1,725 - $4,457	7,190 Added 887.65%	8,000 $2,000
Q3 2022 Nov 09, 2022	SELL	$0.75 - $1.2 $11,847 - $18,956	-15,797 Reduced 95.12%	810 $1,000
Q2 2022 Aug 11, 2022	SELL	$0.88 - $2.27 $156 - $404	-178 Reduced 1.06%	16,607 $16,000
Q1 2022 May 12, 2022	SELL	$1.83 - $3.97 $946 - $2,052	-517 Reduced 2.99%	16,785 $39,000
Q4 2021 Feb 11, 2022	BUY	$3.43 - $4.22 $59,345 - $73,014	17,302 New	17,302 $63,000
Q1 2021 May 12, 2021	SELL	$4.74 - $7.94 $232 - $389	-49 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$3.61 - $11.4 $176 - $558	49 New	49 $0

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.